Home › Venous Thromboembolism › New York › New York City
Venous Thromboembolism clinical trials in New York City, NY
6 studies for Venous Thromboembolism are looking for participants at sites in and around New York City (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
REGN7508 in Adult Participants for Prevention of Cancer-Associated Thrombosis
RecruitingPhase 3
- Memorial Sloan Kettering Cancer Center, New York
Treatment and Secondary Prevention of Venous Thromboembolism (VTE) in Adult Participants With Solid and Hematologic Cancers
RecruitingPhase 3
- Memorial Sloan Kettering Cancer Center, New York
Aspiration Thrombectomy Using the Symphony or Prodigy System
RecruitingObservational study
- Mount Sinai Hospital, New York
DEFIANCE: RCT of ClotTriever System Versus Anticoagulation In Deep Vein Thrombosis
Recruiting
- NYU Langone Medical Center, New York
- Columbia University Irving Medical Center, New York
Catheter-Related Early Thromboprophylaxis With Enoxaparin Studies
RecruitingPhase 2/3
- Hassenfeld Children's Hospital, New York
- New York Presbyterian Hospital, New York
Using a Blood Test and Software Tool to Guide Treatment for Venous Thromboembolism
Recruiting
- Memorial Sloan Kettering Cancer Center (All Protocol Activites), New York
Venous Thromboembolism trials in other cities
- Boston, MA7 studies
- Houston, TX4 studies
- Dallas, TX4 studies
- Miami, FL3 studies
- Tampa, FL3 studies
- Jacksonville, FL3 studies
- Sarasota, FL3 studies
- Cleveland, OH3 studies
- Philadelphia, PA3 studies
- New Haven, CT3 studies
Other studies in New York City
- Breast Cancer136 studies
- Non-Small Cell Lung Cancer121 studies
- Cancer (all types)109 studies
- Prostate Cancer103 studies
- Metastatic Cancer93 studies
- Colorectal Cancer78 studies
- Ovarian Cancer69 studies
- Lung Cancer60 studies
- Multiple Myeloma60 studies
- Pancreatic Cancer60 studies
- Endometrial Cancer52 studies
- Acute Myeloid Leukemia51 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.